Skip to main content
OpenTrials
Recruiting

NCT Number: NCT01617382

Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed

The purpose of this study is to register the follow-up data of patients who, because of a peritoneal surface malignancy, will undergo cytoreductive surgery and HIPEC.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Peritoneal Carcinomatosis Abdominal Neoplasms Adenocarcinoma Adenocarcinoma, Mucinous Body Temperature Changes Carcinoma Digestive System Diseases Digestive System Neoplasms Fever Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms, Cystic, Mucinous, and Serous Neoplasms, Glandular and Epithelial Pathological Conditions, Signs and Symptoms Peritoneal Diseases Peritoneal Mesothelioma Peritoneal Neoplasms Pseudomyxoma Peritonei Signs and Symptoms

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

To register the follow-up data of patients who, because of a peritoneal surface malignancy, will undergo cytoreductive surgery and HIPEC. In this surgical intervention, the abdominal cavity is macroscopically cleared of tumor, by removing all visible tumor nodules, and is subsequently rinsed with hyperthermic (heated) chemotherapy, aiming to destroy all residual invisible tumor cells that might have stayed behind after the debulking.

The eventual aim of this procedure is to improve the prognosis/survival of patients with malignancies localized on the peritoneal surface.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with peritoneal carcinomatosis of colorectal origin, patients with pseudomyxoma peritonei (type DPAM or PMCA) and patients with peritoneal mesothelioma who are planned to undergo cytoreductive surgery and HIPEC because of a peritoneal surface malignancy

Treatment and study plan

Primary outcomes

  1. To improve the prognosis/survival of patients with malignancies localized on the peritoneal surface.

    Time frame: Follow-up over a time period of at least 5 years

Study contacts

Contact information is provided by the study sponsor or research team.

Isabelle B Terrasson

CONTACT

[email protected]

+32 16 340837

Sponsors and collaborators

Lead sponsor

Universitaire Ziekenhuizen KU Leuven

Other

Registry information

Official study title

Register With Data From Patients With the Diagnosis of a Peritoneal Surface Malignancy, for Which Cytoreductive Surgery and Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) is Performed

Acronym: HIPEC

Important dates

Study start
2012
Primary completion
2028
Study completion
2028
First posted
Jun 12, 2012
Registry last updated
Jun 26, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.